Advisory Agreements in the Pharmaceuticals Industry
26 Contracts & Agreements
- Acer Therapeutics Inc. (2 contracts)
- Anacor Pharmaceuticals, Inc. (2)
- ARADIGM CORP (1)
- Elixir Pharmaceuticals, Inc. (1)
- Eloxx Pharmaceuticals, Inc. (1)
- Exactus, Inc. (1)
- HARROW HEALTH, INC. (3)
- INNOVATE BIOPHARMACEUTICALS, INC. (1)
- Jaguar Health, Inc. (1)
- Level Brands, Inc. (5)
- MJ Holdings, Inc. (1)
- MYnd Analytics, Inc. (1)
- PLx Pharma Inc. (1)
- RADIENT PHARMACEUTICALS Corp (2)
- RELMADA THERAPEUTICS, INC. (1)
- Scopus BioPharma Inc. (1)
- TAURIGA SCIENCES, INC. (1)
- Advisory Agreement dated as of January 1, 2023, between Relmada Therapeutics, Inc., and Paul Kelly (RELMADA THERAPEUTICS, INC., Filed With SEC on January 5, 2023)
- Board advisory agreement with Dr. Loucks dated May 15, 2021 (TAURIGA SCIENCES, INC., Filed With SEC on June 29, 2021)
- China Life Science Advisory Agreement, dated October 8, 2019, by and between Jaguar Health, Inc. and Angel Pond Capital LLC (Jaguar Health, Inc., Filed With SEC on October 22, 2019)
- Form of Scientific Advisory Board Member Agreement (Scopus BioPharma Inc., Filed With SEC on August 15, 2019)
- Advisory Agreement dated January 15, 2019 with Joseph Gunnar LLC (Level Brands, Inc., Filed With SEC on February 14, 2019)
- Amendment to Advisory Agreement dated January 14, 2019 with Maxim Group LLC (Level Brands, Inc., Filed With SEC on February 14, 2019)
- Advisory Board Charter (Exactus, Inc., Filed With SEC on January 14, 2019)
- Corporate Advisory Agreement dated June 22, 2018, by and among MJ Holdings, Inc., Profesco, Inc., and Terrence M. Tierney (MJ Holdings, Inc., Filed With SEC on November 15, 2018)
- Advisory Agreement dated March 8, 2018 by and between Level Brands, Inc. and Stephen Roseberry (Level Brands, Inc., Filed With SEC on May 15, 2018)
- Advisory Agreement dated March 8, 2018 by and between Level Brands, Inc. and Tommy Meharey (Level Brands, Inc., Filed With SEC on May 15, 2018)
- Advisory Agreement dated March 8, 2018 by and between Level Brands, Inc. and Nic Mendoza (Level Brands, Inc., Filed With SEC on May 15, 2018)
- AMENDMENT TO BUSINESS ADVISORY AGREEMENT (Acer Therapeutics Inc., Filed With SEC on July 19, 2017)
- BUSINESS ADVISORY AGREEMENT Prepared For September 2015 ACER THERAPEUTICS INC. BUSINESS ADVISORY AGREEMENT (Acer Therapeutics Inc., Filed With SEC on July 19, 2017)
- TANDON DIGITAL,INC. ADVISORY BOARD MEMBER AGREEMENT (INNOVATE BIOPHARMACEUTICALS, INC., Filed With SEC on November 10, 2015)
- PLX PHARMA INC. SCIENTIFIC ADVISORY BOARD AGREEMENT (PLx Pharma Inc., Filed With SEC on October 5, 2015)
- AMENDMENT 4 TO ANACOR PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Anacor Pharmaceuticals, Inc., Filed With SEC on March 16, 2015)
- AMENDMENT TO ADVISORY AGREEMENT (HARROW HEALTH, INC., Filed With SEC on July 25, 2012)
- Senior Advisory Agreement, dated as of January 17, 2012, by and between Imprimis Pharmaceuticals, Inc. and Paul Finnegan, M.D (HARROW HEALTH, INC., Filed With SEC on May 10, 2012)
- Exhibit 10.4 Advisory Agreement (HARROW HEALTH, INC., Filed With SEC on April 27, 2012)
- ADVISORY AGREEMENT (MYnd Analytics, Inc., Filed With SEC on April 25, 2012)
- AMENDMENT 3 TO ANACOR PHARMACEUTICALS, INC. ADVISORY BOARD AGREEMENT (Anacor Pharmaceuticals, Inc., Filed With SEC on March 15, 2012)
- INVESTMENT ADVISORY AGREEMENTBETWEEN RADIENT PHARMACEUTICALS CORP., AND GALILEO ASSET MANAGEMENT SA (RADIENT PHARMACEUTICALS Corp, Filed With SEC on February 14, 2012)
- AMENDMENT TO ADVISORY AGREEMENT (RADIENT PHARMACEUTICALS Corp, Filed With SEC on February 14, 2012)
- Aradigm Corporation International Scientific Advisory Agreement (ARADIGM CORP, Filed With SEC on December 19, 2008)
- AMENDMENT NO. 1 TO FINANCIAL ADVISORY AGREEMENT (Eloxx Pharmaceuticals, Inc., Filed With SEC on February 14, 2008)
- ELIXIR PHARMACEUTICALS, INC. CONSULTATION AND CLINICAL ADVISORY BOARD AGREEMENT (Elixir Pharmaceuticals, Inc., Filed With SEC on September 21, 2007)
